Hearing Loss Disease Treatment Market Share, Size, Trends, Industry Analysis Report, By Product (Devices, Drugs); By Disease Type; By End-User; By Region; Segment Forecast, 2023 - 2032
The global hearing loss disease treatment market size is expected treach USD 19.99 billion by 2032, according ta new study by Polaris Market Research. The report “Hearing Loss Disease Treatment Market Share, Size, Trends, Industry Analysis Report, By Product (Devices, Drugs); By Disease Type; By End-Use; By Region; Segment Forecast, 2023 - 2032” gives a detailed insight intcurrent market dynamics and provides analysis on future market growth.
The primary drivers of the industry's expansion are the rising incidence of hearing loss, age-related sensorineural degeneration, and public awareness of the disease. The industry stands tbenefit financially from the introduction of new treatment options in the coming years. The products industry is benefiting from rising technological advancements like AI-related innovations. The customer experience is being improved by the introduction of products with cutting-edge features like smartphone compatibility and waterproof, rechargeable devices. For instance, Custom made by Resound, a rechargeable hearing aid that supports wireless streaming from Android and iOS, was introduced by GN Hearing, in June 2022.
More than 5% of the global population, around 430 Mn people, will require rehabilitation in 2021 tmanage their hearing disability, as per the statistics published by the WHO. Additionally, it is anticipated that nearly 2.5 billion people worldwide will have a listening impairment, by 2050.
Key players are putting intaction strategic initiatives that are further propelling the industry, such as new launches, collaborations, agreements, and financial investments. For instance, Autigen and Boehringer Ingelheim signed a collaboration and licensing agreement in April 2022 tdevelop cutting-edge treatments for sensorineural conditions.
In 2021, Fennec Pharmaceuticals announced in September 2022 that the FDA had granted approval tPedmarkto, which prevents hearing loss in children undergoing chemotherapy. Oticon Medical published a blog for the PontLoaner Program. Steroids are thought tbe the most common treatment for hearing loss, including SSNHL and SNHL caused by an autoimmune disease.
Also, neurotrophic factors were thought tbe one of the best drug-based treatments for NIHL tfix the ribbon synapse, keep primary auditory neurons from dying, and make it easier for auditory neuron fibers tgrow back after severe SNHL. Because of wireless technology, twhearing aids can work together as a complete system. The information transfer rate of wireless hearing aids is measured in nanoseconds, which is faster than the human brain's ability tdetect sounds.
Hearing Loss Disease Treatment Market Report Highlights
Devices segment is anticipated tregister the fastest growth rate during the forecast period, owing tsurge in innovative products and services
In 2022, sensorineural segment garnered largest revenue share due tits high prevalence rate of hearing loss disease.
In 2022, North America dominated the global industry due tfactors such as increased disease prevalence, high awareness among healthcare professionals about novel therapies, and improved healthcare access in the region.
The global players include Acousia Therapeutics, Astellas Pharma, Audifon, Audina Hearing Instrument, Frequency Therapeutics, Otonomy, Pipeline Therapeutics, Sensorion, Novartis, and WS Audiology.
Polaris Market Research has segmented the hearing loss disease treatment market report based on product, disease type, end-use, and region:
Hearing Loss Disease Treatment, Product Outlook (Revenue - USD Billion, 2019 - 2032)
Devices
Drugs
Systemic steroids
Antiviral medication
Vasodilators
Others
Hearing Loss Disease Treatment, Disease Type Outlook (Revenue - USD Billion, 2019 - 2032)
Conductive Hearing Loss
Sensorineural Hearing Loss
Mixed
Hearing Loss Disease Treatment, End-Use Outlook (Revenue - USD Billion, 2019 - 2032)
Hospitals
Otology Clinics
Ambulatory Clinics
Hearing Loss Disease Treatment, Regional Outlook (Revenue - USD Billion, 2019 - 2032)
North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Latin America
Argentina
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
- 1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
- 2. Executive Summary
- 2.1. Market Highlights
- 3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
- 4. Global Hearing Loss Disease Treatment Market Insights
- 4.1. Hearing Loss Disease Treatment Market – End-Use Snapshot
- 4.2. Hearing Loss Disease Treatment Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising Prevalence Of Hearing Loss
- 4.2.1.2. Strong R&D Pipeline
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Poor Reimbursement Facilities In Low- And Middle-Income Countries
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Hearing Loss Disease Treatment Market End-Use Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
- 5. Global Hearing Loss Disease Treatment Market, by Product
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Hearing Loss Disease Treatment Market, by Product, 2019-2032 (USD Billion)
- 5.3. Devices
- 5.3.1. Global Hearing Loss Disease Treatment Market, by Devices, by Region, 2019-2032 (USD Billion)
- 5.4. Drugs
- 5.4.1. Global Hearing Loss Disease Treatment Market, by Drugs, by Region, 2019-2032 (USD Billion)
- 5.5. Systemic Steroids
- 5.5.1. Global Hearing Loss Disease Treatment Market, by Systemic Steroids, by Region, 2019-2032 (USD Billion)
- 5.6. Antiviral medication
- 5.6.1. Global Hearing Loss Disease Treatment Market, by Antiviral medication, by Region, 2019-2032 (USD Billion)
- 5.7. Vasodilators
- 5.7.1. Global Hearing Loss Disease Treatment Market, by Vasodilators, by Region, 2019-2032 (USD Billion)
- 5.8. Others
- 5.8.1. Global Hearing Loss Disease Treatment Market, by Others, by Region, 2019-2032 (USD Billion)
- 6. Global Hearing Loss Disease Treatment Market, by Disease Type
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Hearing Loss Disease Treatment Market, by Disease Type, 2019-2032 (USD Billion)
- 6.3. Conductive Hearing loss
- 6.3.1. Global Hearing Loss Disease Treatment Market, by Conductive Hearing loss, by Region, 2019-2032 (USD Billion)
- 6.4. Sensorineural Hearing Loss
- 6.4.1. Global Hearing Loss Disease Treatment Market, by Sensorineural Hearing Loss, by Region, 2019-2032 (USD Billion)
- 6.5. Mixed
- 6.5.1. Global Hearing Loss Disease Treatment Market, by Mixed, by Region, 2019-2032 (USD Billion)
- 7. Global Hearing Loss Disease Treatment Market, by End-Use
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Hearing Loss Disease Treatment Market, by End-Use, 2019-2032 (USD Billion)
- 7.3. Hospitals
- 7.3.1. Global Hearing Loss Disease Treatment Market, by Hospitals, By Region, 2019-2032 (USD Billion)
- 7.4. Otology clinics
- 7.4.1. Global Hearing Loss Disease Treatment Market, by Otology clinics, By Region, 2019-2032 (USD Billion)
- 7.5. Ambulatory clinics
- 7.5.1. Global Hearing Loss Disease Treatment Market, by Ambulatory clinics, By Region, 2019-2032 (USD Billion)
- 8. Global Hearing Loss Disease Treatment Market, by Geography
- 8.1. Key findings
- 8.2. Introduction
- 8.2.1. Hearing Loss Disease Treatment Market Assessment, By Geography, 2019-2032 (USD Billion)
- 8.3. Hearing Loss Disease Treatment Market – North America
- 8.3.1. North America: Hearing Loss Disease Treatment Market, by Product, 2019-2032 (USD Billion)
- 8.3.2. North America: Hearing Loss Disease Treatment Market, by End-Use, 2019-2032 (USD Billion)
- 8.3.3. North America: Hearing Loss Disease Treatment Market, by Disease Type, 2019-2032 (USD Billion)
- 8.3.4. Hearing Loss Disease Treatment Market – U.S.
- 8.3.4.1. U.S.: Hearing Loss Disease Treatment Market, by Product, 2019-2032 (USD Billion)
- 8.3.4.2. U.S.: Hearing Loss Disease Treatment Market, by End-Use, 2019-2032 (USD Billion)
- 8.3.4.3. U.S.: Hearing Loss Disease Treatment Market, by Disease Type, 2019-2032 (USD Billion)
- 8.3.5. Hearing Loss Disease Treatment Market – Canada
- 8.3.5.1. Canada: Hearing Loss Disease Treatment Market, by Product, 2019-2032 (USD Billion)
- 8.3.5.2. Canada.: Hearing Loss Disease Treatment Market, by End-Use, 2019-2032 (USD Billion)
- 8.3.5.3. Canada: Hearing Loss Disease Treatment Market, by Disease Type, 2019-2032 (USD Billion)
- 8.4. Hearing Loss Disease Treatment Market – Europe
- 8.4.1. Europe: Hearing Loss Disease Treatment Market, by Product, 2019-2032 (USD Billion)
- 8.4.2. Europe.: Hearing Loss Disease Treatment Market, by End-Use, 2019-2032 (USD Billion)
- 8.4.3. Europe: Hearing Loss Disease Treatment Market, by Disease Type, 2019-2032 (USD Billion)
- 8.4.4. Hearing Loss Disease Treatment Market – UK
- 8.4.4.1. UK: Hearing Loss Disease Treatment Market, by Product, 2019-2032 (USD Billion)
- 8.4.4.2. UK.: Hearing Loss Disease Treatment Market, by End-Use, 2019-2032 (USD Billion)
- 8.4.4.3. UK: Hearing Loss Disease Treatment Market, by Disease Type, 2019-2032 (USD Billion)
- 8.4.5. Hearing Loss Disease Treatment Market – France
- 8.4.5.1. France: Hearing Loss Disease Treatment Market, by Product, 2019-2032 (USD Billion)
- 8.4.5.2. France.: Hearing Loss Disease Treatment Market, by End-Use, 2019-2032 (USD Billion)
- 8.4.5.3. France: Hearing Loss Disease Treatment Market, by Disease Type, 2019-2032 (USD Billion)
- 8.4.6. Hearing Loss Disease Treatment Market – Germany
- 8.4.6.1. Germany: Hearing Loss Disease Treatment Market, by Product, 2019-2032 (USD Billion)
- 8.4.6.2. Germany.: Hearing Loss Disease Treatment Market, by End-Use, 2019-2032 (USD Billion)
- 8.4.6.3. Germany: Hearing Loss Disease Treatment Market, by Disease Type, 2019-2032 (USD Billion)
- 8.4.7. Hearing Loss Disease Treatment Market – Italy
- 8.4.7.1. Italy: Hearing Loss Disease Treatment Market, by Product, 2019-2032 (USD Billion)
- 8.4.7.2. Italy.: Hearing Loss Disease Treatment Market, by End-Use, 2019-2032 (USD Billion)
- 8.4.7.3. Italy: Hearing Loss Disease Treatment Market, by Disease Type, 2019-2032 (USD Billion)
- 8.4.8. Hearing Loss Disease Treatment Market – Spain
- 8.4.8.1. Spain: Hearing Loss Disease Treatment Market, by Product, 2019-2032 (USD Billion)
- 8.4.8.2. Spain.: Hearing Loss Disease Treatment Market, by End-Use, 2019-2032 (USD Billion)
- 8.4.8.3. Spain: Hearing Loss Disease Treatment Market, by Disease Type, 2019-2032 (USD Billion)
- 8.4.9. Hearing Loss Disease Treatment Market – Netherlands
- 8.4.9.1. Netherlands: Hearing Loss Disease Treatment Market, by Product, 2019-2032 (USD Billion)
- 8.4.9.2. Netherlands.: Hearing Loss Disease Treatment Market, by End-Use, 2019-2032 (USD Billion)
- 8.4.9.3. Netherlands: Hearing Loss Disease Treatment Market, by Disease Type, 2019-2032 (USD Billion)
- 8.4.10. Hearing Loss Disease Treatment Market – Russia
- 8.4.10.1. Russia: Hearing Loss Disease Treatment Market, by Product, 2019-2032 (USD Billion)
- 8.4.10.2. Russia.: Hearing Loss Disease Treatment Market, by End-Use, 2019-2032 (USD Billion)
- 8.4.10.3. Russia: Hearing Loss Disease Treatment Market, by Disease Type, 2019-2032 (USD Billion)
- 8.5. Hearing Loss Disease Treatment Market – Asia Pacific
- 8.5.1. Asia Pacific: Hearing Loss Disease Treatment Market, by Product, 2019-2032 (USD Billion)
- 8.5.2. Asia Pacific.: Hearing Loss Disease Treatment Market, by End-Use, 2019-2032 (USD Billion)
- 8.5.3. Asia Pacific: Hearing Loss Disease Treatment Market, by Disease Type, 2019-2032 (USD Billion)
- 8.5.4. Hearing Loss Disease Treatment Market – China
- 8.5.4.1. China: Hearing Loss Disease Treatment Market, by Product, 2019-2032 (USD Billion)
- 8.5.4.2. China.: Hearing Loss Disease Treatment Market, by End-Use, 2019-2032 (USD Billion)
- 8.5.4.3. China: Hearing Loss Disease Treatment Market, by Disease Type, 2019-2032 (USD Billion)
- 8.5.5. Hearing Loss Disease Treatment Market – India
- 8.5.5.1. India: Hearing Loss Disease Treatment Market, by Product, 2019-2032 (USD Billion)
- 8.5.5.2. India.: Hearing Loss Disease Treatment Market, by End-Use, 2019-2032 (USD Billion)
- 8.5.5.3. India: Hearing Loss Disease Treatment Market, by Disease Type, 2019-2032 (USD Billion)
- 8.5.6. Hearing Loss Disease Treatment Market – Malaysia
- 8.5.6.1. Malaysia: Hearing Loss Disease Treatment Market, by Product, 2019-2032 (USD Billion)
- 8.5.6.2. Malaysia.: Hearing Loss Disease Treatment Market, by End-Use, 2019-2032 (USD Billion)
- 8.5.6.3. Malaysia: Hearing Loss Disease Treatment Market, by Disease Type, 2019-2032 (USD Billion)
- 8.5.7. Hearing Loss Disease Treatment Market – Japan
- 8.5.7.1. Japan: Hearing Loss Disease Treatment Market, by Product, 2019-2032 (USD Billion)
- 8.5.7.2. Japan.: Hearing Loss Disease Treatment Market, by End-Use, 2019-2032 (USD Billion)
- 8.5.7.3. Japan: Hearing Loss Disease Treatment Market, by Disease Type, 2019-2032 (USD Billion)
- 8.5.8. Hearing Loss Disease Treatment Market – Indonesia
- 8.5.8.1. Indonesia: Hearing Loss Disease Treatment Market, by Product, 2019-2032 (USD Billion)
- 8.5.8.2. Indonesia.: Hearing Loss Disease Treatment Market, by End-Use, 2019-2032 (USD Billion)
- 8.5.8.3. Indonesia: Hearing Loss Disease Treatment Market, by Disease Type, 2019-2032 (USD Billion)
- 8.5.9. Hearing Loss Disease Treatment Market – South Korea
- 8.5.9.1. South Korea: Hearing Loss Disease Treatment Market, by Product, 2019-2032 (USD Billion)
- 8.5.9.2. South Korea.: Hearing Loss Disease Treatment Market, by End-Use, 2019-2032 (USD Billion)
- 8.5.9.3. South Korea: Hearing Loss Disease Treatment Market, by Disease Type, 2019-2032 (USD Billion)
- 8.6. Hearing Loss Disease Treatment Market – Middle East & Africa
- 8.6.1. Middle East & Africa: Hearing Loss Disease Treatment Market, by Product, 2019-2032 (USD Billion)
- 8.6.2. Middle East & Africa.: Hearing Loss Disease Treatment Market, by End-Use, 2019-2032 (USD Billion)
- 8.6.3. Middle East & Africa: Hearing Loss Disease Treatment Market, by Disease Type, 2019-2032 (USD Billion)
- 8.6.4. Hearing Loss Disease Treatment Market – Saudi Arabia
- 8.6.4.1. Saudi Arabia: Hearing Loss Disease Treatment Market, by Product, 2019-2032 (USD Billion)
- 8.6.4.2. Saudi Arabia.: Hearing Loss Disease Treatment Market, by End-Use, 2019-2032 (USD Billion)
- 8.6.4.3. Saudi Arabia: Hearing Loss Disease Treatment Market, by Disease Type, 2019-2032 (USD Billion)
- 8.6.5. Hearing Loss Disease Treatment Market – UAE
- 8.6.5.1. UAE: Hearing Loss Disease Treatment Market, by Product, 2019-2032 (USD Billion)
- 8.6.5.2. UAE.: Hearing Loss Disease Treatment Market, by End-Use, 2019-2032 (USD Billion)
- 8.6.5.3. UAE: Hearing Loss Disease Treatment Market, by Disease Type, 2019-2032 (USD Billion)
- 8.6.6. Hearing Loss Disease Treatment Market – Israel
- 8.6.6.1. Israel: Hearing Loss Disease Treatment Market, by Product, 2019-2032 (USD Billion)
- 8.6.6.2. Israel.: Hearing Loss Disease Treatment Market, by End-Use, 2019-2032 (USD Billion)
- 8.6.6.3. Israel: Hearing Loss Disease Treatment Market, by Disease Type, 2019-2032 (USD Billion)
- 8.6.7. Hearing Loss Disease Treatment Market – South Africa
- 8.6.7.1. South Africa: Hearing Loss Disease Treatment Market, by Product, 2019-2032 (USD Billion)
- 8.6.7.2. South Africa.: Hearing Loss Disease Treatment Market, by End-Use, 2019-2032 (USD Billion)
- 8.6.7.3. South Africa: Hearing Loss Disease Treatment Market, by Disease Type, 2019-2032 (USD Billion)
- 8.7. Hearing Loss Disease Treatment Market – Latin America
- 8.7.1. Latin America: Hearing Loss Disease Treatment Market, by Product, 2019-2032 (USD Billion)
- 8.7.2. Latin America.: Hearing Loss Disease Treatment Market, by End-Use, 2019-2032 (USD Billion)
- 8.7.3. Latin America: Hearing Loss Disease Treatment Market, by Disease Type, 2019-2032 (USD Billion)
- 8.7.4. Hearing Loss Disease Treatment Market – Mexico
- 8.7.4.1. Mexico: Hearing Loss Disease Treatment Market, by Product, 2019-2032 (USD Billion)
- 8.7.4.2. Mexico.: Hearing Loss Disease Treatment Market, by End-Use, 2019-2032 (USD Billion)
- 8.7.4.3. Mexico: Hearing Loss Disease Treatment Market, by Disease Type, 2019-2032 (USD Billion)
- 8.7.5. Hearing Loss Disease Treatment Market – Brazil
- 8.7.5.1. Brazil: Hearing Loss Disease Treatment Market, by Product, 2019-2032 (USD Billion)
- 8.7.5.2. Brazil.: Hearing Loss Disease Treatment Market, by End-Use, 2019-2032 (USD Billion)
- 8.7.5.3. Brazil: Hearing Loss Disease Treatment Market, by Disease Type, 2019-2032 (USD Billion)
- 8.7.6. Hearing Loss Disease Treatment Market – Argentina
- 8.7.6.1. Argentina: Hearing Loss Disease Treatment Market, by Product, 2019-2032 (USD Billion)
- 8.7.6.2. Argentina.: Hearing Loss Disease Treatment Market, by End-Use, 2019-2032 (USD Billion)
- 8.7.6.3. Argentina: Hearing Loss Disease Treatment Market, by Disease Type, 2019-2032 (USD Billion)
- 9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
- 10. Company Profiles
- 10.1. Acousia Therapeutics
- 10.1.1. Company Overview
- 10.1.2. Financial PerDisease Typeance
- 10.1.3. Disease Type Benchmarking
- 10.1.4. Recent Development
- 10.2. Astellas Pharma
- 10.2.1. Company Overview
- 10.2.2. Financial PerDisease Typeance
- 10.2.3. Disease Type Benchmarking
- 10.2.4. Recent Development
- 10.3. Audifon GmbH
- 10.3.1. Company Overview
- 10.3.2. Financial PerDisease Typeance
- 10.3.3. Disease Type Benchmarking
- 10.3.4. Recent Development
- 10.4. Audina Hearing Instrument
- 10.4.1. Company Overview
- 10.4.2. Financial PerDisease Typeance
- 10.4.3. Disease Type Benchmarking
- 10.4.4. Recent Development
- 10.5. Frequency Therapeutics
- 10.5.1. Company Overview
- 10.5.2. Financial PerDisease Typeance
- 10.5.3. Disease Type Benchmarking
- 10.5.4. Recent Development
- 10.6. Otonomy
- 10.6.1. Company Overview
- 10.6.2. Financial PerDisease Typeance
- 10.6.3. Disease Type Benchmarking
- 10.6.4. Recent Development
- 10.7. Pipeline Therapeutics
- 10.7.1. Company Overview
- 10.7.2. Financial PerDisease Typeance
- 10.7.3. Disease Type Benchmarking
- 10.7.4. Recent Development
- 10.8. Sensorion
- 10.8.1. Company Overview
- 10.8.2. Financial PerDisease Typeance
- 10.8.3. Disease Type Benchmarking
- 10.8.4. Recent Development
- 10.9. Novartis
- 10.9.1. Company Overview
- 10.9.2. Financial PerDisease Typeance
- 10.9.3. Disease Type Benchmarking
- 10.9.4. Recent Development
- 10.10. WS Audiology
- 10.10.1. Company Overview
- 10.10.2. Financial PerDisease Typeance
- 10.10.3. Disease Type Benchmarking
- 10.10.4. Recent Development
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook